Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eija Korkeila

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|October 24, 2012
[Pancreatic adenocarcinoma--a therapeutic challenge]Eija Korkeila, Saila Kauhanen, Miia Mokka
Duodecim; Laaketieteellinen Aikakauskirja|April 20, 2007
[Not Available]Eija Korkeila, Sirkku Jyrkkiö, Seppo Pyrhönen
Anticancer Research|July 31, 2012
Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancerEija Korkeila, Jari Sundström, Seppo Pyrhönen, et al.
Virchows Archiv : an International Journal of Pathology|October 13, 2010
The expression and distribution of group IIA phospholipase A2 in human colorectal tumoursTuulia Avoranta, Jari Sundström, Eija Korkeila, et al.
World Journal of Gastroenterology|August 30, 2008
Up-regulation of alpha-catenin is associated with increased lymph node involvement in colorectal cancerAdam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, et al.
Plos One|September 28, 2017
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancerKhadija Slik, Samu Kurki, Taina Korpela, et al.
World Journal of Gastroenterology|July 9, 2008
Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinomaAdam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, et al.
The American Journal of Surgical Pathology|September 7, 2019
CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal CarcinomaKhadija Slik, Riku Turkki, Olli Carpén, et al.
Human Pathology|August 15, 2008
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancerAdam Elzagheid, Eija Korkeila, Riyad Bendardaf, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastasesRiyad Bendardaf, Adam Elzagheid, Hanan Lamlum, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|October 24, 2012
[Pancreatic adenocarcinoma--a therapeutic challenge]Eija Korkeila, Saila Kauhanen, Miia Mokka
Duodecim; Laaketieteellinen Aikakauskirja|April 20, 2007
[Not Available]Eija Korkeila, Sirkku Jyrkkiö, Seppo Pyrhönen
Anticancer Research|July 31, 2012
Main effects and interactions of carbonic anhydrase IX, hypoxia-inducible factor-1α, ezrin and glucose transporter-1 in multivariate analysis for disease outcome in rectal cancerEija Korkeila, Jari Sundström, Seppo Pyrhönen, et al.
Virchows Archiv : an International Journal of Pathology|October 13, 2010
The expression and distribution of group IIA phospholipase A2 in human colorectal tumoursTuulia Avoranta, Jari Sundström, Eija Korkeila, et al.
World Journal of Gastroenterology|August 30, 2008
Up-regulation of alpha-catenin is associated with increased lymph node involvement in colorectal cancerAdam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, et al.
Plos One|September 28, 2017
Ezrin expression combined with MSI status in prognostication of stage II colorectal cancerKhadija Slik, Samu Kurki, Taina Korpela, et al.
World Journal of Gastroenterology|July 9, 2008
Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinomaAdam Elzagheid, Abdelbaset Buhmeida, Eija Korkeila, et al.
The American Journal of Surgical Pathology|September 7, 2019
CDX2 Loss With Microsatellite Stable Phenotype Predicts Poor Clinical Outcome in Stage II Colorectal CarcinomaKhadija Slik, Riku Turkki, Olli Carpén, et al.
Human Pathology|August 15, 2008
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancerAdam Elzagheid, Eija Korkeila, Riyad Bendardaf, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastasesRiyad Bendardaf, Adam Elzagheid, Hanan Lamlum, et al.
Pageof 2